28462-19-3 Usage
Uses
Used in Pharmaceutical Industry:
2-[Ethyl(3-methylphenyl)amino]ethyl acetate serves as a crucial intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be incorporated into the development of new drugs, enhancing their efficacy and potential therapeutic applications.
Used in Organic Compounds Synthesis:
As an intermediate, 2-[Ethyl(3-methylphenyl)amino]ethyl acetate is used in the production of a wide range of organic compounds. Its versatility in chemical reactions makes it a valuable component in the synthesis of various chemical products, contributing to the advancement of the chemical industry.
Used in Chemical Product Production:
2-[Ethyl(3-methylphenyl)amino]ethyl acetate is commonly employed in the manufacturing process of different chemical products. Its presence in these products is attributed to its ability to improve their properties, such as stability, reactivity, or other desired characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 28462-19-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,4,6 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 28462-19:
(7*2)+(6*8)+(5*4)+(4*6)+(3*2)+(2*1)+(1*9)=123
123 % 10 = 3
So 28462-19-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H19NO2/c1-4-14(8-9-16-12(3)15)13-7-5-6-11(2)10-13/h5-7,10H,4,8-9H2,1-3H3
28462-19-3Relevant academic research and scientific papers
INHIBITORS OF CYSTATHIONINE BETA SYNTHASE TO REDUCE THE NEUROTOXIC OVERPRODUCTION OF ENDOGENOUS HYDROGEN SULFIDE
-
Page/Page column 43, (2013/05/23)
The invention is directed to inhibitors of cystathionine beta synthase which, among other biochemical effects, allow reduction of the neurotoxic overproduction of endogenous hydrogen sulphide. These compounds and pharmaceutical compositions containing them are useful for the prevention and treatment of cognitive disorders such as cognitive disorders in Down syndrome. The invention also relates to methods for preventing or treating cognitive disorders including cognitive disorders in Down Syndrome.
